These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12559378)

  • 1. Dosing time-dependent variation in the hypocalcemic effect of calcitonin in rat.
    Nishiki K; Tsuruoka S; Wakaumi M; Yamamoto H; Koyama A; Fujimura A
    Eur J Pharmacol; 2003 Jan; 460(2-3):171-5. PubMed ID: 12559378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing time-dependent variation of bone resorption by cyclosporin A in rats' femurs.
    Tsuruoka S; Kaneda T; Maeda A; Ioka T; Fujimura A
    Eur J Pharmacol; 2007 Jun; 564(1-3):226-31. PubMed ID: 17362919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alendronate on plasma calcium levels, urinary calcium excretion, and bone resorption markers in normal rats: comparison with elcatonin, synthetic eel calcitonin.
    Azuma Y; Chokki M; Ohta T; Kiyoki M
    Endocrinology; 1996 Jun; 137(6):2586-92. PubMed ID: 8641213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of diet to the dosing time-dependent change of vitamin D3-induced hypercalcemia in rats.
    Tsuruoka S; Sugimoto K; Fujimura A
    Life Sci; 2000 Dec; 68(5):579-89. PubMed ID: 11197755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronopharmacology of oxacalcitriol in 5/6 nephrectomized rats.
    Tsuruoka S; Nishiki K; Wakaumi M; Yamamoto H; Ando H; Ning W; Fujimura A
    Life Sci; 2004 Jul; 75(7):809-22. PubMed ID: 15183074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of hypocalcemia by intracerebroventricular injection of calcitonin: evidence for control of blood calcium by the nervous system.
    Goltzman D; Tannenbaum GS
    Brain Res; 1987 Jul; 416(1):1-6. PubMed ID: 3620946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronopharmacology of oxacalcitriol in rat model of osteoporosis.
    Tsuruoka S; Wakaumi M; Yamamoto H; Fujimura A
    Eur J Pharmacol; 2004 Mar; 488(1-3):239-45. PubMed ID: 15044057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related differences in the hypocalcemic effect of calcitonin and calcium excretion in female rats.
    Tsai CL; Wong TY; Tsai SC; Lau CP; Chen YZ; Hwang GS; Wang PS
    Chin J Physiol; 1991; 34(4):455-62. PubMed ID: 1820846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronotherapy with active vitamin D3 in aged stroke-prone spontaneously hypertensive rats, a model of osteoporosis.
    Tsuruoka S; Nishiki K; Sugimoto K; Fujimura A
    Eur J Pharmacol; 2001 Oct; 428(2):287-93. PubMed ID: 11675047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal iontophoresis of salmon calcitonin can reproduce the hypocalcemic effect of intravenous administration.
    Santi P; Volpato NM; Bettini R; Catellani PL; Massimo G; Colombo P
    Farmaco; 1997; 52(6-7):445-8. PubMed ID: 9372596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the enhanced hypocalcemic action of liposome-entrapped calcitonin.
    Fukunaga M; Miller MM; Deftos LJ
    Calcif Tissue Int; 1990 Dec; 47(6):373-7. PubMed ID: 2292080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin of the stingray: comparison of the hypocalcemic activity with other calcitonins.
    Sasayama Y; Suzuki N; Oguro C; Takei Y; Takahashi A; Watanabe TX; Nakajima K; Sakakibara S
    Gen Comp Endocrinol; 1992 May; 86(2):269-74. PubMed ID: 1601276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats.
    Lee KC; Park MO; Na DH; Youn YS; Lee SD; Yoo SD; Lee HS; DeLuca PP
    Calcif Tissue Int; 2003 Dec; 73(6):545-9. PubMed ID: 14508623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocalcemic effect of salmon calcitonin following single and repeated nasal and intravenous administration in young rabbits.
    Schipper NG; Romeijn SG; Verhoef J; Merkus FW
    Calcif Tissue Int; 1994 Jan; 54(1):50-5. PubMed ID: 8118754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Absence of hypocalcemic response to calcitonin in patients with chronic liver diseases].
    Millán J; Lorenzo A; López Sáez JJ; Escobar M; Morán A; Senra A
    Rev Esp Enferm Apar Dig; 1988 Mar; 73(3):249-52. PubMed ID: 3285392
    [No Abstract]   [Full Text] [Related]  

  • 16. Time of day improves efficacy and reduces adverse reactions of vitamin D3 in 5/6 nephrectomized rat.
    Tsuruoka S; Nishiki K; Sugimoto K; Fujimura A
    Life Sci; 2002 Aug; 71(15):1809-20. PubMed ID: 12151058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmon calcitonin induced hypocalcemia and hyperphosphatemia in an elasmobranch, Dasyatis akajei.
    Srivastav AK; Srivastav SK; Sasayama Y; Suzuki N
    Gen Comp Endocrinol; 1998 Jan; 109(1):8-12. PubMed ID: 9446717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors.
    Ikegame M; Ejiri S; Ozawa H
    Bone; 2004 Jul; 35(1):27-33. PubMed ID: 15207738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the hypocalcemic actions of salmon calcitonin and ultimobranchial gland extracts in the freshwater teleost Cyprinus carpio.
    Chakrabarti P; Mukherjee D
    Gen Comp Endocrinol; 1993 Jun; 90(3):267-73. PubMed ID: 8224753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcimimetic compound NPS R-568 stimulates calcitonin secretion but selectively targets parathyroid gland Ca(2+) receptor in rats.
    Fox J; Lowe SH; Conklin RL; Petty BA; Nemeth EF
    J Pharmacol Exp Ther; 1999 Aug; 290(2):480-6. PubMed ID: 10411553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.